PHC (PARIS HEPATOLOGY CONFERENCE) 2018 – Slides
- 08:30 - 08:45 Introduction: Liver Diseases: a large scale sceening is needed - Patrick MARCELLIN (France) Download
-
08:45 - 09:50
HEPATITIS C - SESSION 1
Chairs :
Michael MANNS (Germany) Tarik ASSELAH (France)
- 08:45 - 09:00 Treatment of HCV: 100 % cure ? - Tarik ASSELAH (France) Download
- 09:00 - 09:15 Difficult to treat patients - Stefan ZEUZEM (Germany) Download
- 09:15 - 09:30 Results in real life - Christophe HEZODE (France) Download
- 09:30 - 09:50 Round table discussion
- 09:50 - 10:10 CLINICAL CASE
- Management of a patient with HCV related vasculitis - Eugene SCHIFF (USA) Download
- 10:10 - 10:40 Coffee Break
-
10:40 - 11:45
HEPATITIS C - SESSION 2
Chairs :
Mitchell SHIFFMAN (USA) Marc BOURLIERE (France)
- 10:40 - 10:55 Cost benefit of treatment in F1 patients - Graham FOSTER (UK) Download
- 10:55 - 11:10 Special populations - Stanislas POL (France) Download
- 11:10 - 11:25 The next wave of HCV : The epidemic of intravenous drug use - Mitchell SHIFFMAN (USA) Download
- 11:25 - 11:45 Round table discussion
-
11:45 - 12:30
State of the art LECTURE and award
Chairman:
Patrick MARCELLIN (France)
-
12:30 - 14:30 Luncheon workshops 1-How to improve access to treatment in HCV patients
Chairs: Graham FOSTER (UK) Gamal ESMAT (Egypt) Download
2-Optimal treatment strategy in HCV patients
Chairs: Geoffrey DUSHEIKO (UK) Adrian GADANO (Argentina)
3-Treatment strategy in patients with HIV-HCV co-infection
Chairs: Mitchell SHIFFMAN (USA) Stanislas POL (France)
4-Delta hepatitis: current epidemiology and optimized therapy
Chairs: Mario RIZZETTO (Italy) Download Christian TREPO (France)
5-Optimal management of auto-immune hepatitis
Chairs: Michael MANNS (Germany) Peter GALLE (Germany)
6-Treatment of HCC in real life
Chairs: Peter FERENCI (Austria) Olivier ROSMORDUC (France)
7-Optimisation de la prise en charge d’un patient avec ascite (French speaking lunch workshop)
Chairs: Philippe MATHURIN (France) Christophe MORENO (Belgium)
Speakers:
Claire FRANCOZ (France)
Mustapha BENAZZOUZ (Morocco) Download
Jean-Charles DUCLOS VALLEE (France)
-
14:30 - 15:45
NASH SESSION
Chairs :
Lawrence SERFATY (France) Arun SANYAL (USA)
- 14:30 - 14:45 Worldwide Epidemiology of NAFLD - Stefano BELLENTANI (Italy) Download
- 14:45 - 15:00 Prognosis of NASH - Jean François DUFOUR (Switzerland) Download
- 15:00 - 15:15 Management of a patient with NASH in real life - Lawrence SERFATY (France) Download
- 15:15 - 15:30 Future therapies in NASH - Arun SANYAL (USA) Download
- 15:30 - 15:45 Round table discussion
-
15:45 - 16:15
CONTROVERSY: diagnosis of NASH
Chairs :
Lawrence SERFATY (France) Arun SANYAL (USA)
- 15:45 Liver Biopsy - Pierre BEDOSSA (France) Download
- 16:00 Indirect markers - Laurent CASTERA (France) Download
- 16:15 - 16:35 Coffee break
- 16:35 - 18:10 Around the World Table: Access to HCV therapy
- Introduction - Patrick MARCELLIN (France) Download
- Western countries - Speakers: Michael FRIED (USA) Download Maria BUTI (Spain) Download Massimo COLOMBO (Italy) Download Graham FOSTER (UK) Victor DE LEDINGHEN (France) Download Thomas BERG (Germany) Download
- Other countries - Speakers: Mustapha BENAZZOUZ (Morocco) Download Robert FLISIAK (Poland) Vasily ISAKOV (Russia) Adriana POPESCU (Romania) Raymundo PARANA (Brazil) Gamal ESMAT (Egypt) Download
- Special communication - How to manage liver patients during war - Speaker: Nabil ANTAKI (Syria) Download
- 18:10 Take home messages - Marc BOURLIERE (France) Download
- 18:20 Conclusion - Patrick MARCELLIN (France)
- 18:40 - 20:00 Industry satellite symposium
- 07:30 - 08:30 Industry satellite symposium
- 08:30 - 08:45 Introduction - Patrick MARCELLIN (France) Download
-
08:45 - 09:50
HEPATITIS B - SESSION 1
Chairs :
Jidong JIA (China) Georgios PAPATHEODORIDIS (Greece)
- 08:45 - 09:00 Who and when to treat ? - Georgios PAPATHEODORIDIS (Greece) Download
- 09:00 - 09:15 Is there still a role for interferon ? - Pietro LAMPERTICO (Italy) Download
- 09:15 - 09:30 Long term safety and efficacy of NUCs - Maria BUTI (Spain) Download
- 09:30 - 09:50 Round table discussion
-
09:50 - 10:20
CONTROVERSY: To stop or not to stop NUCs ?
Chairman:
Georgios PAPATHEODORIDIS (Greece)
- YES - Thomas BERG (Germany)
- NO - Adrian GADANO (Argentina)
- 10:20 - 10:40 Coffee Break
-
10:40 - 11:40
HEPATITIS B - SESSION 2
Chairs :
Rafael ESTEBAN (Spain) Shiv SARIN (India)
- 10:40 - 10:55 New anti-HBV therapies - Raymond SCHINAZI (USA)
- 10:55 - 11:10 Delta hepatitis revisited - Mario RIZZETTO (Italy) Download
- 11:10 - 11:25 How to improve access to therapy for HBV patients? - Fabien ZOULIM (France) Download
- 11:25 - 11:40 Round table discussion
-
11:40 - 12:10
How to control HBV in high endemic regions?
Chairman:
Patrick MARCELLIN (France)
- Asia - Jidong JIA (China) Download
- Sub-saharian African - Lamine DIOUF (Senegal) Download
-
12:10 - 12:30
State of the art LECTURE
Chairman:
Patrick MARCELLIN (France)
- The revolution of imagery in liver diseases - Valérie VILGRAIN (France) Download
-
12:30 - 14:30 Luncheon Workshops 1-How to diagnose NASH?
Chairs: Arun SANYAL (USA) Pierre BEDOSSA (France)
2-How to manage patients with NASH?
Chairs: Lawrence SERFATY (France) Stefano BELLENTANI (Italy)
3-Long term benefits and side effects of NUC therapy for HBV.
Chairs: Rafael ESTEBAN (Spain) Pietro LAMPERTICO (Italy)
4-New therapeutic strategies in HBV patients
Chairs: Massimo LEVRERO (France) Download Thomas BERG (Germany)
5-Liver transplantation issues in 2018
Chairs: Didier SAMUEL (France) Pierre-Alain CLAVIEN (Switzerland)
6-Diagnostic et prise en charge d’un patient avec NASH (French speaking lunch workshop)
Chairs: Daniel DHUMEAUX (France) Jean-François David CADRANEL (France)
-
14:30 - 15:30
END STAGE LIVER DISEASE AND TRANSPLANTATION
Chairs :
Richard MOREAU (France) François DURAND (France)
- 14:30 - 14:45 Infections complicating cirrhosis - Paolo ANGELI (Italy) Download
- 14:45 - 15:00 Allocation of liver grafts throughout the world. What is the best system? - Pierre-Alain CLAVIEN (Switzerland)
- 15:00 - 15:15 How to improve the long-term outcome after liver transplantation - François DURAND (France) Download
- 15:15 - 15:30 Round table discussion
-
15:30 - 15:50
State of the art LECTURE
Chairman:
Patrick MARCELLIN (France)
- Vascular liver diseases: Current management and new concepts - Dominique VALLA (France) Download
-
15:50 - 16:50
HCC SESSION
Chairs :
Massimo COLOMBO (Italy) Didier SAMUEL (France)
- 15:50 - 16:05 Updated 2018 EASL CPGs - Peter GALLE (Germany) Download
- 16:05 - 16:20 The impact of DAAs on HCC occurence - Didier SAMUEL (France) Download
- 16:20 - 16:35 New approaches in therapy - Bruno SANGRO (Spain) Download
- 16:35 - 16:50 Round table discussion
- 16:50 - 17:00 Take home messages - Michael FRIED (USA)
- 17:00 - 17:15 Conclusion - Patrick MARCELLIN (France)
- 17:30 Ajournement